Lumen Names Ashley Haynes-Gaspar Chief Revenue Officer
Seasoned leader expands role to reinforce Lumen’s customer focused transformation and growth DENVER, Jan. 5, 2024 /PRNewswire/ — Lumen Technologies (NYSE: LUMN) names Ashley Haynes-Gaspar as Executive Vice President and Chief Revenue Officer. Formerly Executive Vice President – Custom
BD Announces Webcast of Annual Meeting of Shareholders
FRANKLIN LAKES, N.J., Jan. 5, 2024 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will host a live webcast of its Annual Meeting of Shareholders on Tuesday, January 23, 2024, at 1:00 p.m. (ET). The audio webca
INB Now Offering $6,000 in Downpayment Assistance for Homebuyers
SPRINGFIELD, Ill., Jan. 5, 2024 /PRNewswire/ — Starting today, INB, N.A. mortgage lenders can provide Illinois homebuyers with up to $6,000 to help them purchase a new home. The program, IHDAccess Forgivable, assists borrowers who qualify for a loan, but may not have enough funds to cover down
MIND Technology Announces Deferral of Preferred Stock Dividend
THE WOODLANDS, Texas, Jan. 5, 2024 /PRNewswire/ — MIND Technology, Inc. (“MIND” or the “Company”) (Nasdaq: MIND) announced today that the Company’s Board of Directors (the “Board”) has elected not to declare a quarterly cash dividend on its 9.00% Serie
Newmark Announces Pricing Of $600 Million of 7.500% Senior Notes
NEW YORK, Jan. 5, 2024 /PRNewswire/ — Newmark Group, Inc. (Nasdaq: NMRK) (“Newmark” or the “Company”), today announced the pricing of its offering of $600.0 million aggregate principal amount of its 7.500% senior notes (the “notes”). The notes will be genera
PRECISIO BIOTIX TO PRESENT AT BIOTECH SHOWCASE™ 2024 and BFC GLOBAL HEALTHCARE CONFERENCE
Presentation by CEO Mark Engel Highlighting both Platform and Product Pipeline Advances DOVER, Del., Jan. 5, 2024 /PRNewswire/ — Precisio Biotix today announced that it is presenting at both the BFC Global Healthcare Conference and Biotech Showcase™ 2024. Mark Engel, Chairman and CEO will b
United States Additive Manufacturing for Military and Defense Market Research Report 2023: From Concept to Deployment – The Future of Critical Asset Development
DUBLIN, Jan. 5, 2024 /PRNewswire/ — The “Additive Manufacturing for Military and Defense: Market Analysis and Forecast” report has been added to ResearchAndMarkets.com’s offering. “Additive Manufacturing for Military and Defense” focuses on the United States mil
Servier and Base4 Expand Partnership to Advance Neuroscience Drug Development
Base4’s drug discovery platform allows its collaborators to evaluate billions of novel small molecules to identify and progress RNA-modulators for important diseases. DURHAM, N.C., Jan. 5, 2024 /PRNewswire/ — Base4 Biotechnology (formerly known as Nymirum) today announced that it has ex
FDA Roundup: January 05, 2024
SILVER SPRING, Md., Jan. 5, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Wednesday, the FDA issued a safety communication to inform health care providers not to use the Total Hip System, including resu
CIVC Partners Announces Partner Promotion
CHICAGO, Jan. 5, 2024 /PRNewswire/ — CIVC Partners, LP (“CIVC”), a Chicago-based middle market private equity firm, is pleased to announce the promotion of Sloan Wilson to Partner in connection with the activation of our newest fund, CIVC Partners Fund VII, earlier this month. S
